Use of a chemotherapy toxicity prediction tool to decrease the risks for hospitalization in the elderly.

Authors

Mintcho Mintchev

Mintcho Elinov Mintchev

Brooke Army Medical Center, San Antonio, TX

Mintcho Elinov Mintchev, Adrian Reyes Bersabe

Organizations

Brooke Army Medical Center, San Antonio, TX, SAUSHEC, Fort Sam Houston, TX

Research Funding

Other

Background: Oncologists commonly use performance status scores such as ECOG and Karnofsky when making treatment decisions. However, there is limited data on the utility of these measures in selecting therapy and predicting treatment-related complications in the elderly. In July 2016, medical oncologists at our institution made it standard practice to use the Cancer and Aging Research Group toxicity prediction score (CARG) to identify elderly patients who are “fit” for conventional therapy versus those who are “frail” and may experience increased complications. Methods: We retrospectively reviewed referrals to our outpatient medical oncology clinic for patients 75 years of age and older. Referrals leading to systemic therapy (i.e. chemotherapy, targeted therapy, and immunotherapy) or changes to conventional therapy based on CARG were included in our study. We evaluated CARG utilization during the 6 months before and the 6 months after its institution. We also assessed how changes to therapy due to CARG impacted admissions and emergency department (ED) visits. Results: Thirty-eight patients with mean age of 81.2 years, 52.6% male, met inclusion criteria. Their diagnoses included GI (36.8%), lung (21.1%), hematologic (18.4%), breast (10.5%), GU (2.6%), and other (10.5%) malignancies. During 2016, CARG was assessed in 14 patients, 9 of whom received systemic therapy. CARG was assessed in 12.5% and 41.2% of patients receiving systemic therapy in the 6-month periods before and after its incorporation, respectively. Patients whose therapy was decreased in intensity or withheld based on CARG had fewer mean admissions (0.7 versus 2.25), days of admission (4.3 versus 8), and ED visits (1.1 versus 2.5) compared to those who received conventional therapy. However, the study lacked power to establish statistical significance. Conclusions: A CARG assessment occurred in less than 50% of elderly cancer patients who received systemic therapy and further inquiry may help formulate interventions to increase its adoption. Therapy modifications based on CARG may lead to fewer hospitalizations, admission days, and ED visits, but more consistent use of the score and further investigation are necessary.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Abstract Details

Meeting

2018 ASCO Quality Care Symposium

Session Type

Poster Session

Session Title

Poster Session B: Projects Relating to Patient Experience; Projects Relating to Safety; Technology and Innovation in Quality of Care

Track

Projects Relating to Patient Experience,Projects Relating to Safety,Technology and Innovation in Quality of Care

Sub Track

Standardization Efforts to Improve Safety

Citation

J Clin Oncol 36, 2018 (suppl 30; abstr 256)

DOI

10.1200/JCO.2018.36.30_suppl.256

Abstract #

256

Poster Bd #

J12

Abstract Disclosures

Similar Abstracts

First Author: Jasmine L Martin

First Author: Mintcho Elinov Mintchev

Abstract

2022 ASCO Annual Meeting

Factors associated to hospitalizations in older cancer patients treated with chemotherapy.

First Author: Claudia Bordignon